Cambridge, Canada

Jalaj Arora


 

Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 136(Granted Patents)


Location History:

  • Cambridge, CA (2002 - 2008)
  • Mississauga, CA (2001 - 2009)
  • Toronto, CA (2006 - 2009)
  • Milton, CA (2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jalaj Arora

Introduction

Jalaj Arora is a prominent inventor based in Cambridge, Canada, known for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he has made remarkable strides in developing compounds that address neurological and psychiatric disorders.

Latest Patents

Among his latest patents are "Piperazines and piperidines as Mglur5 potentiators" and "Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists." The first patent focuses on compounds that can be used in therapies for disorders associated with glutamate dysfunction. The second patent relates to new compounds that can prevent or treat mGluR5 receptor-mediated disorders, showcasing his commitment to advancing medical science.

Career Highlights

Jalaj has worked with notable companies such as AstraZeneca and NPS Allelix Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, Jalaj has collaborated with talented individuals, including Abdelmalik Slassi and Methvin Benjamin Isaac. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Jalaj Arora's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations reflect a dedication to improving therapies for complex disorders, making a lasting impact on medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…